Taken together, these data demonstrate that inhibition of PAD2 in RA-ILD fibroblasts attenuates their profibrotic phenotype, marked by decreased myofibroblast differentiation and extracellular matrix production. The gene discussed is PADI2; the disease is rheumatoid arthritis.